Symbol
Travere Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$14.99
Current price of the stock
$3M
Trading volume of the stock
$1.2B
Market capitalization of the company
Small Cap
Category of market capitalization
-
Long-term growth mean estimate
4.75
Mean analyst rating
126.37%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-12.43
Total debt to total equity ratio
1.71
Current ratio
97.41%
Gross profit margin
-89.27%
Operating profit margin
-89.27%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-87.18%
Pretax profit margin
-87.14%
Net profit margin
179.79%
Measures profitability relative to shareholders' equity
40.66%
ROE excluding intangible assets
-10.85%
Measures profitability relative to total assets
-19.59%
Measures profitability relative to invested capital
0.12
Asset turnover ratio
0.26
Inventory turnover ratio
2.50
Receivables turnover ratio
36.02
Average number of days it takes to collect receivables
-3.38
Measures valuation relative to earnings
-
P/E based on future earnings estimates
5.73
Measures valuation relative to sales
-38.35
Measures valuation relative to book value
-1.50
Measures valuation relative to operating cash flow
-1.50
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
